LPZ 15 ap (Lansoprazole Delayed-Release 15 mg)

Pill with imprint LPZ 15 ap is Blue & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Ajanta Pharma Limited.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LPZ 15 ap

Lansoprazole Delayed-Release

Imprint

LPZ 15 ap

Strength

15 mg

Color

Blue & Pink

Size

16.00 mm

Shape

Capsule-shape

Availability

Rx and/or OTC

Drug Class

Proton pump inhibitors

Pregnancy Category

B - No proven risk in humans

CSA Schedule

Not a controlled drug

Labeler / Supplier

Ajanta Pharma Limited

National Drug Code (NDC)

27241-0019

Inactive Ingredients

sucrose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, low substituted hydroxypropyl cellulose, magnesium carbonate, magnesium silicate, polyethylene glycol, hydroxypropyl cellulose (type h), silicon dioxide, hypromelloses, ferric oxide red, ferrosoferric oxide, ferric oxide yellow, sodium bicarbonate, sodium lauryl sulfate, shellac, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer